Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Echo Therapeutics Inc (NASDAQ:ECTE)

1.76
Delayed Data
As of 1:44pm ET
 0.00 / 0.00%
Today’s Change
0.39
Today|||52-Week Range
3.00
+30.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues19.1K19.1K0.000.00
 
 
 
Depreciation And Amortization98.9K97.9K96.0K86.7K
 
 
 
 
 
 
Operating ExpensesGross Income-----96.0K-86.7K
 
 
 
General Expenses3.8M2.8M2.7M2.3M
 
 
 
 
 
Research And Development1.7M1.2M613.4K831.3K
 
 
 
 
 
Total Operating Expenses3.9M2.9M2.8M2.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-2.9M-2.8M-2.4M
 
 
 
 
 
Extraordinary Credit393.0K473.0K----
 
 
 
Extraordinary Charge0.000.00-95.0K-257.8K
 
 
 
Interest Expense On Debt243.8K3.1M0.00--
 
 
 
Other Expenses1.5K0.00-2.6K-5.6M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.8M-5.5M-2.9M-8.3M
 
 
 
 
 
Income Taxes0.000.00-4.0K0.00
 
 
Preferred Dividend0.000.00-350.0K0.00
 
 
Net Income-3.8M-5.5M-2.9M-8.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.1M12.7M12.6M11.5M
 
 
 
 
 
Shares To Calculate EPS Diluted12.1M12.7M12.6M11.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.43-$0.26-$0.72
 
 
 
 
 
EPS Diluted-$0.31-$0.43-$0.26-$0.72